Macquarie Group
GBIO

Macquarie Group’s Generation Bio GBIO Stock Holding History

Macquarie Group’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50
Closed -$3.13K – 2482
2022
Q2 		$3K Hold
50
– – ﹤0.01% 2549
2022
Q1 		$4 Hold
50
– – ﹤0.01% 2599
2021
Q4 		$4K Hold
50
– – ﹤0.01% 2579
2021
Q3 		$12K Hold
50
– – ﹤0.01% 2525
2021
Q2 		$13K Sell
50
-29
-37% -$8.68K ﹤0.01% 2442
2021
Q1 		$23K Buy
+79
New +$25.3K ﹤0.01% 2247

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group's GBIO Position: Q3 2022 in Review

Macquarie Group sold out of Generation Bio (GBIO) in Q3 2022, closing a stake of 50 shares — an estimated $3.13K sold.

Macquarie Group first reported a position in GBIO in Q1 2021 and held it in 6 quarters. The position peaked at $23K in Q1 2021. 111 funds tracked by Wall St. Rank hold GBIO as of Q3 2022.

  • Macquarie Group reported no remaining Generation Bio position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 50 Generation Bio shares in Q3 2022, an estimated $3.13K.
  • Macquarie Group first reported a position in Generation Bio in Q1 2021 and held it in 6 quarters.
  • Macquarie Group's Generation Bio position peaked at $23K in Q1 2021.
  • 111 funds tracked by Wall St. Rank held Generation Bio as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.